Life sciences-focused cloud startup Benchling has seen its business soar over the last few years, amid a renewed interest in biotech among investors. Benchling CEO Sajith Wickramasekara joins Caroline Hyde and Ed Ludlow to discuss the state of the global biopharma industry and its adoption of technology. He speaks on “Bloomberg Technology.”
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:
Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:
Get the latest in tech from Silicon Valley and around the world here:
Connect with us on…
Twitter:
Facebook:
Instagram:
source
























